Cargando…
Effect on Adherence to Nicotine Replacement Therapy of Informing Smokers Their Dose Is Determined by Their Genotype: A Randomised Controlled Trial
BACKGROUND: The behavioural impact of pharmacogenomics is untested. We tested two hypotheses concerning the behavioural impact of informing smokers their oral dose of NRT is tailored to analysis of DNA. METHODS AND FINDINGS: We conducted an RCT with smokers in smoking cessation clinics (N = 633). In...
Autores principales: | Marteau, Theresa M., Aveyard, Paul, Munafò, Marcus R., Prevost, A. Toby, Hollands, Gareth J., Armstrong, David, Sutton, Stephen, Hill, Chloe, Johnstone, Elaine, Kinmonth, Ann Louise |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3324463/ https://www.ncbi.nlm.nih.gov/pubmed/22509402 http://dx.doi.org/10.1371/journal.pone.0035249 |
Ejemplares similares
-
Trial Protocol: Using genotype to tailor prescribing of nicotine replacement therapy: a randomised controlled trial assessing impact of communication upon adherence
por: Marteau, Theresa M, et al.
Publicado: (2010) -
The association of rs1051730 genotype on adherence to and consumption of prescribed nicotine replacement therapy dose during a smoking cessation attempt
por: Ware, Jennifer J., et al.
Publicado: (2015) -
Trial Protocol: Communicating DNA-based risk assessments for Crohn's disease: a randomised controlled trial assessing impact upon stopping smoking
por: Whitwell, Sophia CL, et al.
Publicado: (2011) -
Open science prevents mindless science
por: Munafò, Marcus R, et al.
Publicado: (2018) -
The impact of communicating genetic risks of disease on risk-reducing health behaviour: systematic review with meta-analysis
por: Hollands, Gareth J, et al.
Publicado: (2016)